US life expectancy stalls due to cardiovascular disease, not drug deaths - PubMed (original) (raw)
US life expectancy stalls due to cardiovascular disease, not drug deaths
Neil K Mehta et al. Proc Natl Acad Sci U S A. 2020.
Abstract
After decades of robust growth, the rise in US life expectancy stalled after 2010. Explanations for the stall have focused on rising drug-related deaths. Here we show that a stagnating decline in cardiovascular disease (CVD) mortality was the main culprit, outpacing and overshadowing the effects of all other causes of death. The CVD stagnation held back the increase of US life expectancy at age 25 y by 1.14 y in women and men, between 2010 and 2017. Rising drug-related deaths had a much smaller effect: 0.1 y in women and 0.4 y in men. Comparisons with other high-income countries reveal that the US CVD stagnation is unusually strong, contributing to a stark mortality divergence between the US and peer nations. Without the aid of CVD mortality declines, future US life expectancy gains must come from other causes-a monumental task given the enormity of earlier declines in CVD death rates. Reversal of the drug overdose epidemic will be beneficial, but insufficient for achieving pre-2010 pace of life expectancy growth.
Keywords: cardiovascular disease; drug-related mortality; life expectancy; mortality; opioid epidemic.
Copyright © 2020 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no competing interest.
Figures
Fig. 1.
Age-standardized death rates (per 100,000 person-years) from drug-related causes and CVD. Gray shaded lines are trends for individual US states and Washington, DC. US data are from the CDC Wonder Database. Longevity leaders is the average of countries that had the highest life expectancy at birth in year 2010 (Japan, Switzerland, Singapore, Australia, Spain, Iceland, Italy, Israel, Sweden, and France). Non-US data are from WHO Cause of Death Database. Sexes are combined. CVD deaths include deaths from heart attacks and strokes (ICD 10: I00 to I78). Drug-related causes include ICD 10: X40 to X44, X60 to X64, X85, and Y10 to Y14.
Fig. 2.
Actual and simulated life expectancy at age 25 y during 2010–2017 in men and women. Drug-related counterfactual is estimated by holding age-specific drug-related mortality fixed at its 2010 level through 2017. CVD counterfactual is estimated by extrapolating average age-specific changes in CVD mortality from 2000 to 2009 forward to 2017. Data are from the CDC Wonder database.
Similar articles
- Recent trends in life expectancy across high income countries: retrospective observational study.
Ho JY, Hendi AS. Ho JY, et al. BMJ. 2018 Aug 15;362:k2562. doi: 10.1136/bmj.k2562. BMJ. 2018. PMID: 30111634 Free PMC article. - The contribution of drug-related deaths to the US disadvantage in mortality.
Barbieri M. Barbieri M. Int J Epidemiol. 2019 Jun 1;48(3):945-953. doi: 10.1093/ije/dyy288. Int J Epidemiol. 2019. PMID: 30597015 Free PMC article. - The "double jeopardy" of midlife and old age mortality trends in the United States.
Abrams LR, Myrskylä M, Mehta NK. Abrams LR, et al. Proc Natl Acad Sci U S A. 2023 Oct 17;120(42):e2308360120. doi: 10.1073/pnas.2308360120. Epub 2023 Oct 9. Proc Natl Acad Sci U S A. 2023. PMID: 37812715 Free PMC article. - Increases in United States life expectancy through reductions in injury-related death.
Kegler SR, Baldwin GT, Rudd RA, Ballesteros MF. Kegler SR, et al. Popul Health Metr. 2017 Aug 30;15(1):32. doi: 10.1186/s12963-017-0150-4. Popul Health Metr. 2017. PMID: 28854976 Free PMC article. Review. - Declining Life Expectancy in the United States: Missing the Trees for the Forest.
Harper S, Riddell CA, King NB. Harper S, et al. Annu Rev Public Health. 2021 Apr 1;42:381-403. doi: 10.1146/annurev-publhealth-082619-104231. Epub 2021 Dec 16. Annu Rev Public Health. 2021. PMID: 33326297 Review.
Cited by
- The contribution of avoidable mortality to life expectancy differences and lifespan disparities in the European Union: a population-based study.
Hrzic R, Vogt T. Hrzic R, et al. Lancet Reg Health Eur. 2024 Aug 30;46:101042. doi: 10.1016/j.lanepe.2024.101042. eCollection 2024 Nov. Lancet Reg Health Eur. 2024. PMID: 39286330 Free PMC article. - Life expectancy and geographic variation in mortality: an observational comparison study of six high-income Anglophone countries.
Wilkie RZ, Ho JY. Wilkie RZ, et al. BMJ Open. 2024 Aug 13;14(7):e079365. doi: 10.1136/bmjopen-2023-079365. BMJ Open. 2024. PMID: 39138004 Free PMC article. - Health Prompts Affect Consideration of Health but Not Intertemporal Preferences While Promoting Healthier Food Choices.
Tuyizere O, Gustafson CR, Rose DJ. Tuyizere O, et al. Nutrients. 2024 May 12;16(10):1454. doi: 10.3390/nu16101454. Nutrients. 2024. PMID: 38794692 Free PMC article. - Younger but sicker? Cohort trends in disease accumulation among middle-aged and older adults in Scotland using health-linked data from the Scottish Longitudinal Study.
Ribe E, Cezard GI, Marshall A, Keenan K. Ribe E, et al. Eur J Public Health. 2024 Aug 1;34(4):696-703. doi: 10.1093/eurpub/ckae062. Eur J Public Health. 2024. PMID: 38604658 Free PMC article. - US exceptionalism? International trends in midlife mortality.
Dowd JB, Doniec K, Zhang L, Tilstra A. Dowd JB, et al. Int J Epidemiol. 2024 Feb 14;53(2):dyae024. doi: 10.1093/ije/dyae024. Int J Epidemiol. 2024. PMID: 38508869 Free PMC article.
References
- National Center for Health Statistics, Health, United States, 2005 With Chartbook on Trends in the Health of Americans. https://www.cdc.gov/nchs/data/hus/hus05.pdf. Accessed 1 February 2020.
- Ford E. S., et al. , Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356, 2388–2398 (2007). - PubMed
- Jemal A., Ward E., Hao Y., Thun M., Trends in the leading causes of death in the United States, 1970-2002. JAMA 294, 1255–1259 (2005). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources